Provided herein are intermediates that are useful in methods for producing myeloid cell leukemia 1 protein (Mcl-1) inhibitors of Formula (I), and methods for the preparation of the myeloid cell leukemia 1 protein (Mcl-1) inhibitors using the intermediates.
The compounds of formula (I) and compositions comprising them may be used, for example, in the treatment of diseases or conditions, such as cancer.
本文提供了用于生产式(I)髓系细胞白血病 1 蛋白(Mcl-1)
抑制剂的方法的中间体,以及使用这些中间体制备髓系细胞白血病 1 蛋白(Mcl-1)
抑制剂的方法。
式(I)化合物和包含它们的组合物可用于例如癌症等疾病或病症的治疗。